NCT02821260 Clinical Evaluation of the Efficacity of Epilepsy Surgery in Infants and Children
| NCT ID | NCT02821260 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondation Ophtalmologique Adolphe de Rothschild |
| Condition | Epilepsy |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2015-12 |
| Primary Completion | 2028-09 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2015-12 with a primary completion date of 2028-09.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Pediatric Neurosurgery Service of the Rothschild Foundation (Paris) is the French leader center for surgery of epilepsy in infants and children. Postoperative follow-up of these children is performed during medical and neurosurgical consultations in order to assess the frequency of attacks and to reduce medication. On average, two postoperative consultations are carried out between 3 and 5 months and between 12 and 18 months. Beyond 18 months, some children may benefit from long-term monitoring at this center, but most children are followed by their neurologist . Therefore, the center has no rigorous and systematic collection of standardized data on the outcome of these patients. The purpose of this study is to evaluate the efficacy of the epilepsy surgery in children with a monitoring of 3 years.
Eligibility Criteria
Inclusion Criteria: * Child treated surgically for epilepsy at the Rothschild Foundation (Paris, France) Exclusion Criteria: * Parental opposition to the participation of their child to the study
Contact & Investigator
Christine BULTEAU, MD
✉ cbulteau@fo-rothschild.frFrequently Asked Questions
Who can join the NCT02821260 clinical trial?
This trial is open to participants of all sexes, up to 18 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02821260 currently recruiting?
Yes, NCT02821260 is actively recruiting participants. Contact the research team at cbulteau@fo-rothschild.fr for enrollment information.
Where is the NCT02821260 trial being conducted?
This trial is being conducted at Paris, France.
Who is sponsoring the NCT02821260 clinical trial?
NCT02821260 is sponsored by Fondation Ophtalmologique Adolphe de Rothschild. The trial plans to enroll 500 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.